A novel arctigenin-containing latex glove prevents latex allergy by inhibiting type I/IV allergic reactions

被引:5
作者
Wang Yong-Xin [1 ]
Xue Dan-Ting [1 ]
Liu Meng [1 ]
Zhou Zheng-Min [2 ]
Shang Jing [1 ,3 ,4 ]
机构
[1] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China
[2] Jiangsu Guotai Int Grp Cooperat, Zhangjiagang 215600, Peoples R China
[3] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining 810008, Peoples R China
[4] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Latex allergy; Arctigenin; RBL-2H3; cell; Mouse primary spleen lymphocytes; NATURAL-RUBBER LATEX; CALMODULIN; DERMATITIS; ASTHMA; LIGNAN;
D O I
10.1016/S1875-5364(16)30015-2
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The present study aimed at developing a natural compound with anti-allergic effect and stability under latex glove manufacturing conditions and investigating whether its anti-allergic effect is maintained after its addition into the latex. The effects of nine natural compounds on growth of the RBL-2H3 cells and mouse primary spleen lymphocytes were determined using MTT assay. The compounds included glycyrrhizin, osthole, tetrandrine, tea polyphenol, catechin, arctigenin, oleanolic acid, baicalin and oxymatrine. An ELISA assay was used for the in vitro anti-type I/IV allergy screening; in this process beta-hexosaminidase, histamine, and IL-4 released from RBL-2H3 cell lines and IFN-gamma and IL-2 released from mouse primary spleen lymphocytes were taken as screening indices. The physical stability of eight natural compounds and the dissolubility of arctigenin, selected based on the in vitro pharmacodynamaic screening and the stability evaluation, were detected by HPLC. The in vivo pharmacodynamic confirmation of arctigenin and final latex product was evaluated with a passive cutaneous anaphylaxis (PCA) model and an allergen-specific skin response model. Nine natural compounds showed minor growth inhibition on RBL-2H3 cells and mouse primary spleen lymphocytes. Baicalin and arctigenin had the best anti-type I and IV allergic effects among the natural compounds based on the in vitro pharmacodynamic screening. Arctigenin and catechin had the best physical stability under different manufacturing conditions. Arctigenin was the selected for further evaluation and proven to have anti-type I and IV allergic effects in vivo in a dose-dependent manner. The final product of the arctigenin-containing latex glove had anti-type I and IV allergic effects in vivo which were mainly attributed to arctigenin as proved from the dissolubility results. Arctigenin showed anti-type I and IV allergic effects in vitro and in vivo, with a good stability under latex glove manufacturing conditions, and a persistent anti-allergic effect after being added into the latex to prevent latex allergy.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 37 条
[1]   The implications of latex allergy in healthcare settings [J].
Bowyer, RVSL .
JOURNAL OF CLINICAL NURSING, 1999, 8 (02) :139-143
[2]   Natural rubber latex allergy after 12 years: Recommendations and perspectives [J].
Charous, BL ;
Blanco, C ;
Tarlo, S ;
Hamilton, RG ;
Baur, X ;
Beezhold, D ;
Sussman, G ;
Yunginger, JW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) :31-34
[3]   Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition:: the role in TNF-α inhibition [J].
Cho, MK ;
Jang, YP ;
Kim, YC ;
Kim, SG .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (10-11) :1419-1429
[4]  
d'Auzac J, 1989, PHYSL RUBBER TREE LA
[5]   The use of powdered gloves in dental practice: A cause for concern? [J].
Field, EA .
JOURNAL OF DENTISTRY, 1997, 25 (3-4) :209-214
[6]   Degranulation in RBL-2H3 cells: regulation by calmodulin pathway [J].
Funaba, M ;
Ikeda, T ;
Abe, M .
CELL BIOLOGY INTERNATIONAL, 2003, 27 (10) :879-885
[7]   Characterization of modified allergen extracts by in vitro β-hexosaminidase release from rat basophils [J].
Gehlhar, K ;
Peters, M ;
Brockmann, K ;
van Schijndel, H ;
Bufe, A .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (04) :311-319
[8]  
GELFAND DW, 1991, AM J ROENTGENOL, V156, P1
[9]  
Hamann CP, 1993, AM J CONTACT DERMATI, V4, P4, DOI DOI 10.1097/01634989-199303000-00003
[10]   Markers of mast cell degranulation [J].
Hogan, AD ;
Schwartz, LB .
METHODS, 1997, 13 (01) :43-52